Understanding SARS-CoV-2 and the drugs that might lessen its power
Modest improvements in treatment could make a big difference
THE INTERCONNECTEDNESS of the modern world has been a boon for SARS-CoV-2. Without planes, trains and automobiles the virus would never have got this far, this fast. Just a few months ago it took its first steps into a human host somewhere in or around Wuhan, in the Chinese province of Hubei. As of this week it had caused over 120,000 diagnosed cases of covid-19, from Tromsø to Buenos Aires, Alberta to Auckland, with most infections continuing to go undiagnosed (see article).
This article appeared in the Briefing section of the print edition under the headline “Anatomy of a killer”
From the March 14th 2020 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Briefing
The right in Congress and the courts will reshape Donald Trump’s agenda
As dominant as the new president is, there is still life in Washington’s institutions
How far will Donald Trump go to get rid of illegal immigrants?
It is his signature policy, but the obstacles are daunting
Young customers in developing countries propel a boom in plastic surgery
Falling costs and converging beauty standards spur new habits
The Assad regime’s fall voids many of the Middle East’s old certainties
What if Syria abandoned its hostility to the West and stopped menacing Israel?
Syria has exchanged a vile dictator for an uncertain future
It is not clear how stable or how benign the new regime will be
Gambling is growing like gangbusters in America
Technology and legal changes are spurring a betting bonanza